WOONSOCKET, R.I., Sept. 19, 2019 /PRNewswire/ -- Building on its impact over the past decade, CVS Health (NYSE: CVS) will expand its Project Health campaign to target more underserved and underinsured communities in 2019, with an aim of reaching more at-risk populations with free health and wellness screenings. Project Health offers a no-cost comprehensive health as

BEDFORD, Mass., Sept. 19, 2019 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced commercialization of the HemosIL AcuStar ADAMTS13 Activity Assay in the European Union and other international markets.  For use on the ACL AcuStar® Hemostasis Testing System, this fully automated, chemiluminescent immunoassay offers clinicians rapid, on-demand AD

OMAHA, Neb. and TAMPA, Fla., Sept. 19, 2019 /PRNewswire/ -- WellCare of Nebraska, Inc., a WellCare Health Plans, Inc. (NYSE: WCG) company, announced it has named Robert B. Rhodes, M.D., chief medical officer. In this role, Dr. Rhodes oversees the plan's medical strategy and t

VANCOUVER, Sept. 19, 2019 /PRNewswire/ - Harvest One Cannabis Inc. ("Harvest One" or the "Company") (TSX-V: HVT; OTCQX: HRVOF) congratulates Burb for earning their first two retail cannabis licences in Port Coquitlam, British Columbia. Harvest One owns 19.9% of Burb which is the maximum allowed under

BALTIMORE, Sept. 19, 2019 /PRNewswire/ -- Y-Trap, Inc. has signed a collaboration and license agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company, for the exclusive development of multiple specific antibody-ligand traps for cancer immunotherapy.The collaboration leverages Y-Trap's proprietary pla

EDISON, N.J., Sept. 19, 2019 /PRNewswire/ -- Lily Bioceuticals™, a research-based anti-aging skin care and cosmetics manufacturer announces the launch of BEYOND FLAWLESS™ SECOND SKIN, the first viable 24-hour breathable, water proof, life-like cosmetic synthetic skin to diminish eye bags & wrinkles.   For decades scientists have promise

SALT LAKE CITY, Sept. 19, 2019 /PRNewswire/ -- USANA, a leader in cellular nutrition, is honored to announce its Coenzyme Q10 (CoQ10) supplement —

SOUTH SAN FRANCISCO, Calif., Sept. 19, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc. (Nasdaq: PTLA) today announced the appointment of Ted W. Love, M.D., to its Board of Directors. Dr. Love is a recognized industry leader with more than 25 years of experience in the discovery and development of high impact medicines.

CAMBRIDGE, Mass., and NEW YORK, Sept. 19, 2019 /PRNewswire/ -- Black Diamond Therapeutics, Inc., a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced the appointment of Christopher D. Roberts, Ph.D., as Chief Scientific Of

SAN DIEGO, Sept. 19, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis), for the treatment of various cancers including leukemia, prostate and colorectal, today announced the successful completion of its Phase